Novel NS5B Resistance‐Associated Substitution Emerges Under Failing Sofosbuvir/Ledipasvir Therapy
Lisa Catalli, Sharon K. Martens, Norah A. Terrault, Jacqueline D. Reeves – 29 March 2019
Lisa Catalli, Sharon K. Martens, Norah A. Terrault, Jacqueline D. Reeves – 29 March 2019
Sujit V. Janardhan – 29 March 2019
Laure Elkrief, José Ferrusquia‐Acosta, Audrey Payancé, Lucile Moga, Luis Tellez, Michael Praktiknjo, Bogdan Procopet, Oana Farcau, Victor De Lédinghen, Rustam Yuldashev, Nicolas Tabchouri, Louise Barbier, Jérôme Dumortier, Benjamin Menahem, Marta Magaz, Virginia Hernández‐Gea, Agustin Albillos, Jonel Trebicka, Laurent Spahr, Andrea De Gottardi, Aurélie Plessier, Dominique Valla, Laura Rubbia‐Brandt, Christian Toso, Christophe Bureau, Juan‐Carlos Garcia‐Pagan, Pierre‐Emmanuel Rautou, for VALDIG, an EASL consortium – 29 March 2019 – In patients with idiopathic noncirrhotic portal hypertension
Gavin Cloherty, Emily Butler, Mary Kuhns – 29 March 2019
Jessica G. Labadie, Manish Jain – 29 March 2019
28 March 2019
Julissa Lombardo‐Quezada, Jordi Colmenero, Hugo López‐Pelayo, Carolina Gavotti, Ana Lopez, Gonzalo Crespo, Eva Lopez, Antoni Gual, Anna Lligoña, Miquel Navasa – 28 March 2019 – The selection of liver transplantation (LT) candidates with alcohol‐use disorder (AUD) is influenced by the risk of alcohol relapse (AR) after LT. We aimed to investigate the risk factors of AR after LT and its impact on graft and recipient outcomes.
28 March 2019
28 March 2019
28 March 2019